Long-term Glioblastoma Multiforme Survivors: a Population-based Study
Authors:
Open Access
- 1 August 1998
- journal article
- research article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 25 (3) , 197-201
Abstract
Background: Long-term glioblastoma multiforme survivors (LTGBMS) are uncommon. The frequency which these occur in an unselected population and factors which produce these unusually long survivors are unknown.Objectives: To determine in a population- based study 1) the frequency of LTGBMS in a population and 2) identify which patient, treatment or tumor characteristics would predict which glioblastoma (GBM) patient would become a LTGBMS.Methods: The Alberta Cancer Registry was used to identify all patients diagnosed with GBM in southern Alberta between 1/1/75 - 12/31/91. Patient charts were reviewed and histology re-examined by a blinded neuropathologist. LTGBMS were defined as GBM patients surviving ≥ 3 years after diagnosis. Each LTGBMS was compared to three age-, gender-, and year of diagnosis-matched controls to compare patient, treatment, and tumor factors to GBM patients without long-term survival.Results: There were 279 GBMs diagnosed in the study period. Five (1.8%) survived ≥ three years (range, 3.2-15.8 years). Seven additional long-term survivors, who carried a diagnosis of GBM, were excluded after neuropathologic review; the most common revised diagnosis was malignant oligodendroglioma. LTGBMS (avg. age = 45 years) were significantly younger when compared to all GBM patients (avg. age = 59 years, p - 0.0001) diagnosed in the study period. LTGBMS had a higher KPS at diagnosis (p = 0.001) compared to controls. Tumors from LTGBMS tended to have fewer mitoses and a lower Ki-67 cellular proliferative index compared to controls. Radiation-induced dementia was common and disabling in LTGBMS.Conclusions: These data highlight the dismal prognosis for GBM patients who have both a short median survival and very small chance (1.8%) of long-term survival. The LTGBMS were younger, had a higher performance status, and their tumors tended to proliferate less rapidly than control GBM patients. When long-term survival does occur it is often accompanied by severe treatment-induced dementia.Keywords
This publication has 22 references indexed in Scilit:
- Long-Term Survival in Patients with Malignant AstrocytomaNeurosurgery, 1994
- Cognitive functioning in long-term survivors of high-grade gliomaJournal of Neurosurgery, 1994
- The basis for current treatment recommendations for malignant gliomasJournal of Neuro-Oncology, 1994
- Expression of epidermal growth factor receptor in human glioblastoma multiformeBritish Journal Of Neurosurgery, 1993
- Long-term survival after the diagnosis of malignant glioma: A series of 22 patients surviving more than 4 years after diagnosisSurgical Neurology, 1992
- Effects of treatment on long‐term survivors with malignant astrocytomasAnnals of Neurology, 1990
- Ten-year survival among patients with supratentorial astrocytomas grade III and IVJournal of Neurosurgery, 1988
- Long-term survival and recurrence-free interval in combined surgical, radio- and chemotherapy of malignant brain gliomasClinical Neurology and Neurosurgery, 1985
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Long-Term Postoperative Survival in Two Cases of Glioblastoma MultiformeJournal of Neurosurgery, 1965